References
- Leirisalo M., Skylv G., Kousa M., Voipio‐Pulkki L. M., Suoranta H., Nissila M., et al. Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA‐B27. Arthritis Rheum 1982; 25: 249–59
- Beacock‐Sharp H., Young J. L., Gaston J. S. Analysis of T cell subsets present in the peripheral blood and synovial fluid of reactive arthritis patients. Ann Rheum Dis 1998; 57: 100–6
- Rubin L. A., Nelson D. L. The soluble interleukin‐2 receptor: biology, function, and clinical application. Ann Intern Med 1990; 113: 619–27
- Kuuliala A., Leirisalo‐Repo M., Mottonen T., Hannonen P., Nissila M., Kautiainen H., et al. Predictive value of serum soluble interleukin‐2 receptor levels in early rheumatoid arthritis. Arthritis Rheum 2003; 48 Suppl 9: 438–9
- Choy E. H., Panayi G. S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001; 344: 907–16
- Steiner G., Studnicka‐Benke A., Witzmann G., Hofler E., Smolen J. Soluble receptors for tumor necrosis factor and interleukin‐2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis. J Rheumatol 1995; 22: 406–12
- Soderlin M. K., Borjesson O., Kautiainen H., Skogh T., Leirisalo‐Repo M. Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis 2002; 61: 911–15
- Sieper J. Disease mechanisms in reactive arthritis. Curr Rheumatol Rep 2004; 6: 110–16
- Toussirot E., Lafforgue P., Boucraut J., Despieds P., Schiano A., Bernard D., et al. Serum levels of interleukin 1‐beta, tumor necrosis factor‐alpha, soluble interleukin 2 receptor and soluble CD8 in seronegative spondylarthropathies. Rheumatol Int 1994; 13: 175–80
- Baeten D., Moller H. J., Delanghe J., Veys E. M., Moestrup S. K., De Keyser F. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis. Arthritis Rheum 2004; 50: 1611–23
- Smeets T. J., Dolhain R. J., Breedveld F. C., Tak P. P. Analysis of the cellular infiltrates and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis. J Pathol 1998; 186: 75–81
- Berghella A. M., Pellegrini P., Del Beato T., Marini M., Tomei E., Adorno D., et al. The significance of an increase in soluble interleukin‐2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from Th1 to Th2 and back. Cancer Immunol Immunother 1998; 45: 241–9
- Hannu T., Mattila L., Rautelin H., Pelkonen P., Lahdenne P., Siitonen A., et al. Campylobacter‐triggered reactive arthritis: a population‐based study. Rheumatology (Oxford) 2002; 41: 312–18
- Bas S., Kvien T. K., Buchs N., Fulpius T., Gabay C. Lower level of synovial fluid interferon‐gamma in HLA‐B27‐positive than in HLA‐B27‐negative patients with Chlamydia trachomatis reactive arthritis. Rheumatology (Oxford) 2003; 42: 461–7
- Braun J., Yin Z., Spiller I., Siegert S., Rudwaleit M., Liu L., et al. Low secretion of tumor necrosis factor alpha, but no other Th1 or Th2 cytokines, by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis. Arthritis Rheum 1999; 42: 2039–44